Bristol-Myers Squibb Beats Earnings Estimates and More - Presented by: The Aol. On Network

Bristol-Myers Squibb reported higher than expected quarterly earnings on Tuesday, helped by cost cuts and lower taxes. There were concerns over a possible delay in completing its marketing application for a high-profile cancer drug. BMY posted Q1 earnings of 56 cents per share, beating estimates of 43 cents a share, while revenue dipped to $3.81 billion, missing estimates of $3.89 billion. Bristol-Myers Squibb also announced the acquisition of iPierian for $175 million.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 14.56 0.23 ▼ 1.56%
AKS $ 4.68 0.31 ▼ 6.21%
FCX $ 14 1.34 ▲ 10.58%
TVIX $ 3.83 0.21 ▲ 5.80%
F $ 13.56 0.53 ▼ 3.76%
AAPL $ 93.74 1.09 ▼ 1.15%
QQQ $ 105.72 0.56 ▼ 0.53%
VALE $ 5.67 0.05 ▲ 0.89%

As of 4/29/2016, 04:15 PM